Skyrocketing sales of tirzepatide the active ingredient in Mounjaro and Zepbound transformed Eli Lilly $LLY into the most valuable pharmaceutical company in the world, however CEO David Ricks says the company is looking ahead to a successor of the blockbuster drug
Retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and no marketing authorisation application has been approved as of the date of publication of this article
How to Tell If Semaglutide Is Really the Trigger When shedding starts during GLP-1 therapy, its easy to assume the medication is the culprit
GLP-1 receptor agonists may not be suitable for individuals with a history of pancreatitis, kidney disease, or gallbladder issues
The BALANCE Model launching May 2026 is worth watching
However, while promising , its long-term effects on OSA outcomes beyond weight loss require further study
